The recently formed Peterson Health Technology Institute (PHTI) has published its first assessment of the cost-effectiveness of digital health technologies (DHTs), focusin
Amazon has launched a health monitoring programme in partnership with Omada Health that aims to identify people who may be eligible for enrolment into the latter’s disease
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh